Radiotherapy in marginal zone lymphoma

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Deinbeck, Kristin ^a   Geinitz, Hans ^a   Haller, Bernhard ^a   Fakhrian, Khashayar ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Gastric lymphoma; MALT; Marginal zone lymphoma; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CATARACT; CAUSE OF DEATH; CLINICAL ARTICLE; CONJUNCTIVITIS; DIARRHEA; DYSPHAGIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; MALE; MARGINAL ZONE LYMPHOMA; MUCOSA INFLAMMATION; NAUSEA; ORBIT TUMOR; OVERALL SURVIVAL; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; SALVAGE THERAPY; SKIN LYMPHOMA; STOMACH PAIN; STOMACH TUMOR; SURVIVAL RATE; TREATMENT FAILURE; TUMOR LOCALIZATION; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RECURRENCE; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871693322     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-2     Document Type: Article

References (27)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B-cell lymphoma. Cancer 1983, 52:1410-1416. 10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3, 6193858.
2. Isaacson P. The MALT lymphoma concept updated. Ann Oncol 1995, 6:319-320.
3. Yamashita H, Nakagawa K, Asari T. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 2008, 87:412-417. 10.1016/j.radonc.2008.03.012, 18423914.
4. Heinzelmann F, Engelhard M, Ottinger H, et al. Nodal follicular lymphoma: The role of radiotherapy for stages I and II. Strahlenther Onkol 2010, 186:191-196. 10.1007/s00066-010-2090-9, 20354662.
5. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997, 15:1624-1630.
6. Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 2010, 116:3815-3824. 10.1002/cncr.25226, 20564130.
7. Hitchcock S, Ng AK, Fisher DC, et al. Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2002, 52:1058-1066. 10.1016/S0360-3016(01)02714-6, 11958902.
8. Liao Z, Ha CS, McLaughlin P, Manning JT, et al. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression. Int J Radiat Oncol Biol Phys 2000, 48:399-403. 10.1016/S0360-3016(00)00628-3, 10974453.
9. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003, 21:4157-4164. 10.1200/JCO.2003.06.085, 14615444.
10. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 2001, 50:1258-1264. 10.1016/S0360-3016(01)01549-8, 11483337.
11. Tomita N, Kodaira T, Tachibana H, et al. Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma. Radiother Oncol 2009, 90:231-235. 10.1016/j.radonc.2008.12.004, 19135751.
12. Isobe K, Kagami Y, Higuchi K, et al. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG). Int J Radiat Oncol Biol Phys 2007, 69:1181-1186. 10.1016/j.ijrobp.2007.04.029, 17601683.
13. Wenzel C, Fiebiger W, Dieckmann K, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 2003, 97:2236-2241. 10.1002/cncr.11317, 12712477.
14. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003, 101:2489-2495. 10.1182/blood-2002-04-1279, 12456507.
15. Anacak Y, Miller RC, Constantinou N, et al. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2012, 82:315-320. 10.1016/j.ijrobp.2010.09.046, 21075560.
16. Bolek TW, Moyses HM, Marcus RB. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999, 44:31-36. 10.1016/S0360-3016(98)00535-5, 10219791.
17. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998, 16:1916-1921.
18. Camacho FI, Algara P, Mollejo M, et al. Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 2003, 27:762-771. 10.1097/00000478-200306000-00006, 12766579.
19. Berger F, Felman P, Thieblemont C, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000, 95:1950-1956.
20. Haidenberger A, Fromm-Haidenberger S, de Vries A. Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (rituximab®) for patients with Non-Hodkin's lymphoma results of a prospective phase I/II study. Strahlenther Onkol 2011, 187:300-305. 10.1007/s00066-011-2169-y, 21544528.
21. Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 2000, 46:1093-1103. 10.1016/S0360-3016(99)00522-2, 10725618.
22. Fung CY, Tarbell NJ, Lucarelli MJ. Ocular adnexal lymphoma: clinical behavior of distinct world health organization classification subtypes. Int J Radiat Oncol Biol Phys 2003, 57:1382-1391. 10.1016/S0360-3016(03)00767-3, 14630277.
23. Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2005, 63:866-871. 10.1016/j.ijrobp.2005.03.005, 15925453.
24. Bessell EM, Henk JM, Wright JE, Whitelocke RA. Orbital and conjunctival lymphoma treatment and prognosis. Radiother Oncol 1988, 13:237-244. 10.1016/0167-8140(88)90218-6, 3217539.
25. Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011, 100:86-92. 10.1016/j.radonc.2011.05.013, 21664710.
26. Fakhrian K, Klemm S, Keller U, et al. Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Strahlenther Onkol 2012, Epub ahead of print.
27. Zucca E, Dreyling M. ESMO guidelines working group. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl 5):175-176.